DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Reaney M, Yu M, vanBrunt K et al.
Patient-Reported Outcomes with Once Weekly Dulaglutide vs. Insulin Glargine (AWARD-2). Abstract. Poster presented at the 74th Scientific Sessions of the American Diabetes Association.
San Francisco: 13–17 June 2014, 979-P.
We do not assume any responsibility for the contents of the web pages of other providers.